Our data showed that NBAT1 was down-regulated in invasive breast cancer, lung squamous cell carcinoma and adenocarcinoma, hepatic cell carcinoma, chromophobe renal cell carcinoma than in normal tissues. This evidence concerns the gene NBAT1 and chromophobe renal cell carcinoma.